You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 3, March 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Laboratory Sciences
 This Article
 •Full text
 •PDF
 •Correction
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (40)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Dry Eye Syndromes
 •Articles for Residents
 •Alert me on articles by topic

Goblet Cell Numbers and Epithelial Proliferation in the Conjunctiva of Patients With Dry Eye Syndrome Treated With Cyclosporine

Kathleen S. Kunert; Ann S. Tisdale; Ilene K. Gipson

Arch Ophthalmol. 2002;120:330-337.

Objectives  To compare conjunctival goblet cell numbers as well as epithelial turnover in patients with non–Sjögren syndrome–associated keratoconjunctivitis sicca (NSS-KCS) and those with SS-KCS before and after 6 months of treatment with topical cyclosporine A (CsA) ophthalmic emulsion.

Methods  Conjunctival biopsy specimens from 16 patients with NSS-KCS and 12 with SS-KCS were obtained at baseline and after 6 months' therapy with CsA or vehicle alone. Conjunctival biopsy specimens were also obtained from 11 normal subjects. Periodic acid–Schiff staining determined the number of goblet cells present. Immunofluorescence microscopy for Ki-67 localization was used to evaluate the number of actively cycling cells.

Results  Periodic acid–Schiff staining showed fewer goblet cells at baseline in both dry eye populations when compared with normal subjects (P<.001). After 6 months of CsA treatment, conjunctival biopsy specimens of both NSS-KCS and SS-KCS groups revealed an increase in goblet cells compared with baseline (P<.05). More Ki-67–positive cells were observed in NSS-KCS conjunctiva at baseline than in normal conjunctiva (P<.05) whereas numbers of these cells in SS-KCS conjunctiva were similar to normal at baseline. After 6 months of CsA treatment, conjunctival biopsy specimens of NSS-KCS revealed a decrease in Ki-67–labeled cells compared with baseline (P<.001). In contrast, no substantial change was observed for CsA treatment in patients with SS-KCS.

Conclusions  Treatment of dry eye syndrome for 6 months with topical CsA resulted in an increase in goblet cell numbers in patients with NSS-KCS and SS-KCS and a decrease in epithelial turnover in those with NSS-KCS. Reducing ocular surface inflammation might have an effect on the proliferative activity of the epithelium.


From the Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, Mass.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

A Murine Model of Dry Eye Induced by an Intelligently Controlled Environmental System
Chen et al.
IOVS 2008;49:1386-1391.
ABSTRACT | FULL TEXT  

Dry Eye-Induced Conjunctival Epithelial Squamous Metaplasia Is Modulated by Interferon-{gamma}
De Paiva et al.
IOVS 2007;48:2553-2560.
ABSTRACT | FULL TEXT  

Topical ciclosporin in the treatment of ocular surface disorders
Tatlipinar and Akpek
Br. J. Ophthalmol. 2005;89:1363-1367.
ABSTRACT | FULL TEXT  

The Controlled-Environment Chamber: A New Mouse Model of Dry Eye
Barabino et al.
IOVS 2005;46:2766-2771.
ABSTRACT | FULL TEXT  

The treatment of dry eyes
Whitcher
Br. J. Ophthalmol. 2004;88:603-604.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.